secwatch.observer — SEC 8-K summary
======================================

Issuer:     W&T OFFSHORE INC (WTI)
CIK:        0001288403
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001104659-23-053458
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

W&T Offshore appoints Dr. Nancy Chang as independent director, effective April 28, 2023
--------------------------------------------------------------------------------

- Board expanded to five members; Dr. Chang appointed to Audit and NCG Committees and as Chair of ESG Committee.
- Dr. Chang previously CEO of Ansun Biopharma, co-founder/CEO of Tanox, and founder of Apex Capital; extensive board experience.
- Will receive standard non-employee director compensation; entered into indemnification agreement with the company.
- Press release issued May 1, 2023; Dr. Chang will stand for election at upcoming annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1288403/000110465923053458/0001104659-23-053458-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1288403/000110465923053458/tm2313484d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-053458

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer